These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34110097)

  • 1. Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study.
    Migliore S; D'Aurizio G; Maffi S; Ceccarelli C; Ristori G; Romano S; Castaldo A; Mariotti C; Curcio G; Squitieri F
    Brain Behav; 2021 Jul; 11(7):e02151. PubMed ID: 34110097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Oct; 28(12):1717-23. PubMed ID: 24166899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodromal Cognitive Changes as a Prognostic Indicator of Forthcoming Huntington's Disease Severity: A Retrospective Longitudinal Study.
    Migliore S; Bianco SD; Scocchia M; Maffi S; Busi LC; Ceccarelli C; Curcio G; Mazza T; Squitieri F
    Mov Disord Clin Pract; 2024 Apr; 11(4):363-372. PubMed ID: 38264920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Age of Onset on Huntington's Disease Phenotype.
    Kwa L; Larson D; Yeh C; Bega D
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():21. PubMed ID: 32775035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment.
    Migliore S; D'Aurizio G; Scaricamazza E; Maffi S; Ceccarelli C; Ristori G; Romano S; Castaldo A; Fichera M; Curcio G; Squitieri F
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of functional decline in Huntington's disease. Huntington Study Group.
    Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
    Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.
    Zielonka D; Ren M; De Michele G; Roos RAC; Squitieri F; Bentivoglio AR; Marcinkowski JT; Landwehrmeyer GB
    Parkinsonism Relat Disord; 2018 Apr; 49():42-47. PubMed ID: 29326033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data.
    Hwang YS; Oh E; Kim M; Lee CY; Kim HS; Chung SJ; Sung YH; Yoon WT; Cho JH; Lee JH; Kim HJ; Chang HJ; Jeon B; Woo KA; Ko SB; Kwon KY; Moon J; Shin C; Kim YE; Lee JY
    J Neurol Sci; 2023 Sep; 452():120744. PubMed ID: 37541133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Education on Symptom Onset and Severity of Huntington's Disease.
    Cain KK; Flanigan JL; Dalrymple WA; Patrie J; Harrison MB; Barrett MJ
    Mov Disord Clin Pract; 2021 May; 8(4):555-562. PubMed ID: 33981788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinesia in early Huntington's disease.
    Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL
    Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study.
    Cheng YF; Liu KC; Yang TM; Xiao Y; Jiang QR; Huang JX; Zhang S; Wei QQ; Ou RW; Li CY; Gu XJ; Burgunder JM; Shang HF
    Brain Behav; 2023 Nov; 13(11):e3258. PubMed ID: 37849450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep Quality and Related Clinical Manifestations in Huntington Disease.
    Maffi S; Scaricamazza E; Migliore S; Casella M; Ceccarelli C; Squitieri F
    J Pers Med; 2022 May; 12(6):. PubMed ID: 35743649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual Curiosity and Action Initiation are Subtypes of Apathy Affected in Huntington Disease Gene Expansion Carriers.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    Cogn Behav Neurol; 2021 Dec; 34(4):295-302. PubMed ID: 34851867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of dual-task cognitive interference on gait and turning in Huntington's disease.
    Purcell NL; Goldman JG; Ouyang B; Liu Y; Bernard B; O'Keefe JA
    PLoS One; 2020; 15(1):e0226827. PubMed ID: 31910203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.